Results 261 to 270 of about 283,997 (324)

Ultra-low level HIV p24 drives immune activation in antiretroviral therapy-treated people living with HIV. [PDF]

Commun Med (Lond)
Richter E, König J, Büning A, Bechtel T, Casado A, Pušnik J, Crowell TA, Jessen H, Rockstroh JK, Boesecke C, Esser S, Stephan C, Streeck H.   +12 more
europepmc   +1 more source

Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy. [PDF]

Open Forum Infect Dis
Hulgan T, Erlandson KM, Bradford Y, Tassiopoulos K, Wu K, Bares SH, Brown TT, Lake JE, Leonard M, McComsey GA, Ritchie MD, Sax PE, Koethe JR, Haas DW.   +13 more
europepmc   +1 more source

Incidence of antiretroviral therapy regimen modification and associated factors among People Living with HIV in Beijing, China. [PDF]

PLOS Glob Public Health
Mi Y, Wang X, Zeng Y, Guo Y, Wang P, Cheng F, Zhou M.   +6 more
europepmc   +1 more source

Prevalence of Hepatitis D and Its Impact on the Clinical Efficacy of Antiretroviral Therapy in People With HBV/HIV-1 in Guangdong Province, China. [PDF]

Open Forum Infect Dis
He Y, Lin W, Li H, Gu F, Lan X, Liu X, Zhang Y, Li R, He R, Cai W, Tang X, Li L.   +11 more
europepmc   +1 more source

When Antiretroviral Therapy Is Not Enough: A Case Series of Pneumocystis Pneumonia With Pulmonary Complications in HIV-Positive Patients. [PDF]

Cureus
Mohod SV, Sheikh R, Choudhary B, Vijay M, Agrawal G.   +4 more
europepmc   +1 more source

HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012-19: a population-based, longitudinal study.

Lancet Microbe
Martin MA, Reynolds SJ, Foley BT, Nalugoda F, Quinn TC, Kemp SA, Nakalanzi M, Kankaka EN, Kigozi G, Ssekubugu R, Gupta RK, Abeler-Dörner L, Kagaayi J, Ratmann O, Fraser C, Galiwango RM, Bonsall D, Grabowski MK, Rakai Health Sciences Program Members, PANGEA-HIV Members.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

ANTIRETROVIRAL THERAPY

Medical Clinics of North America, 1996
Advances in knowledge of the pathogenesis of HIV infection, coupled with the arrival of new antiviral agents and results from clinical trials, have moved clinicians closer to effective therapy of HIV infection. Despite these advances, many important issues remain unresolved.
S C, Threlkeld, M S, Hirsch
openaire   +3 more sources

An Update on Antiretroviral Therapy

2021
Human immunodeficiency virus (HIV) infection and acquired immune deficiency syndrome (AIDS) still claim many lives across the world. However, research efforts during the last 40 years have led to the approval of over 30 antiretroviral drugs and the introduction of combination therapies that have turned HIV infection into a chronic but manageable ...
Luis, Menéndez-Arias, Samara, Martín-Alonso, Estrella, Frutos-Beltrán   +2 more
openaire   +2 more sources

Antiretroviral therapy and TB

Tropical Doctor, 2006
With the expansion and convergence of the HIV and TB epidemics worldwide, clinicians will increasingly will be called to manage and treat co-infected patients. TB and HIV medications have overlapping and additive toxicities that can complicate therapy.
Swaminathan, Soumya, Luetkemeyer, A, Srikantiah, P, Lin, R, Charlebois, E, Havlir, D V   +5 more
openaire   +2 more sources